BP11107 PTMC, Poly(trimethylene carbonate), Hydroxyl Terminated, IV: 3.0–4.0 dl/g, Mw: 198–285 kDa

PTMC, Poly(trimethylene carbonate), Hydroxyl Terminated, IV: 3.0–4.0 dl/g, Mw: 198–285 kDa Description

This polymer is synthesised to offer a well-controlled intrinsic viscosity and molecular weight distribution, ensuring a balance between processability and mechanical performance. Its hydroxyl termination provides reactive sites for further modification, which is beneficial for tuning degradation rates. The material's physicochemical stability makes it suitable for stringent biomedical environments and advanced research applications.

PTMC, Poly(trimethylene carbonate), Hydroxyl Terminated, IV: 3.0–4.0 dl/g, Mw: 198–285 kDa Applications

1.         Biomedical Applications
- Used as a matrix component in tissue engineering scaffolds to achieve controlled cell growth by leveraging its biocompatibility and tailored degradation rate.
- Applied as a vehicle in localised drug delivery systems to achieve sustained release by utilising its predictable breakdown in physiological conditions.

2.         Industrial Applications
- Serves as an additive in specialty coatings to achieve improved surface properties by leveraging its controlled degradation and polymer compatibility.
- Frequently used as a binder in environmentally sensitive adhesives to achieve enhanced adhesion and longevity through its adjustable mechanical properties.

PTMC, Poly(trimethylene carbonate), Hydroxyl Terminated, IV: 3.0–4.0 dl/g, Mw: 198–285 kDa Packing

The material is packaged in moisture-resistant, sealed containers with an inert gas overlay to minimise oxidation risks. Each container is further secured in anti-static pouches to reduce contamination and handling stress. Storage recommendations include a cool, dry environment to safeguard the polymer's performance characteristics. Custom packaging options are available to meet specific site requirements.

Additional Information

PTMC, Poly(trimethylene carbonate), is a biodegradable and biocompatible polymer widely studied in the field of biomedical materials. Known for its amorphous nature, it exhibits excellent biocompatibility and biodegradability, and remains in a rubbery state with inherent elasticity at body temperature. Its adjustable degradation profile and processability make it well-suited for applications such as soft tissue engineering, flexible implants, and controlled drug delivery systems. Understanding the relationship between its molecular weight and intrinsic viscosity is essential for tailoring its performance in specific biomedical and industrial contexts.

The presence of hydroxyl end groups provides reactive sites for further chemical modification, covalent conjugation, or chain extension, thereby enhancing its versatility in synthesising block copolymers, cross-linked networks, and functionalised biomaterials. This reactive functionality expands its utility in advanced manufacturing, formulation processes, and the development of customised polymeric systems. Ongoing research continues to refine processing techniques to enhance its performance, reliability, and reproducibility across a growing range of applications.

Regulatory Note: This material is intended for industrial and research applications. It is the customer's responsibility to ensure compliance with all relevant safety and regulatory standards in their intended use.